Biological Information
Background Information:
AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. AKT activation relies on the PI3K pathway, and is recognized as a critical node in the pathway. The E17 hotspot is the most characterized of AKT1 mutations, and has been shown to result in activation of the protein. Mutations in AKT1 have also been shown to confer resistance to allosteric kinase inhibitors in vitro. GenBank M63167. S478G with regard to this accession, reported in EMBL BE206796. S473D conflict mimics phosphorylation of S473.
Target Class:
Kinase
Family:
AGC
Sub Family:
Protein Ser/Thr
Protein Name:
Akt1 (PKBalpha)
Protein Aliases:
Protein kinase B|PKB|Protein kinase B alpha|PKB alpha|Proto-oncogene c-Akt|RAC-PK-alpha
Accession Number:
NM_001014431.1; NM_001014432.1; NM_005163.2
UniProt Number:
P31749
Gene Name:
AKT1
Gene ID:
207
Gene Aliases:
RAC|PKB|PRKBA|AKT
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology